Statins Could Help Boost Survival Among Cancer Patients

Share this content:
Statins Could Help Boost Survival Among Cancer Patients
Statins Could Help Boost Survival Among Cancer Patients

TUESDAY, July 12, 2016 (HealthDay News) -- Statins may help lower mortality in patients with four common types of cancer, according to a study presented at the European Society of Cardiology's Frontiers in CardioVascular Biology 2016, held from July 8 to 10 in Florence, Italy.

Rahul Potluri, M.D., a clinical lecturer at the Aston University School of Medicine in Birmingham, U.K., and colleagues collected data on 929,552 patients listed in a clinical database from January 2000 to March 2013. Data on deaths was obtained from the U.K. Office for National Statistics. Among the patients in the study, 7,997 had lung cancer, 5,481 had breast cancer, 4,629 had prostate cancer, and 4,570 had bowel cancer.

After adjusting for factors including age, gender, ethnicity, and common causes of death, the researchers found that those taking statins lived longer than those who were not taking them. Patients taking statins appeared to have a 22 percent lower risk of dying from lung cancer, a 43 percent lower risk of dying from breast cancer, a 47 percent lower risk of dying from prostate cancer, and a 30 percent lower risk of dying from bowel cancer.

"The results of this study strengthen the argument for a clinical trial evaluating the possible protective effect of statins and other routinely used cardiovascular medications in patients with cancer. Whether it is statins and/or other cardiovascular drugs in combination that have an effect on mortality remains to be seen," Potluri said in a news release from the European Society of Cardiology. "Patients with cancer who are at high risk or have established cardiovascular disease should be given statins as per current guidelines. I don't think at the moment we can give statins for cancer per se. But this could change if there was a positive result in the clinical trial."

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ultraviolet B Radiation Exposure Tied to Decreased Risk of Myopia

Ultraviolet B Radiation Exposure Tied to Decreased Risk ...

More exposure to sun's UVB rays between ages 14 and 29 linked to lower risk

Vitamin D in Pregnancy Might Help Prevent MS in Offspring

Vitamin D in Pregnancy Might Help Prevent MS ...

Infants born with low levels of vitamin D may be more likely to develop multiple sclerosis later in life

Dabigatran May Be Better Than Warfarin After Bleeding Episode

Dabigatran May Be Better Than Warfarin After Bleeding ...

Resuming any anticoagulant found safer than stopping the drugs in these cases

is free, fast, and customized just for you!

Already a member?

Sign In Now »